首页> Atherosclerosis> Cholesteryl ester transfer protein: An enigmatic pharmacology - Antagonists and agonists.

Cholesteryl ester transfer protein: An enigmatic pharmacology - Antagonists and agonists.

导出 LinkOut

翻译打印收藏纠错

第一作者： Shizuya,Yamashita

第一单位： Rinku General Medical Center, Izumisano, Osaka, Japan; Department of Community Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan. Electronic address: shizu@imed2.med.osaka-u.ac.jp.

作者： Shizuya,Yamashita ^[1] ; Massimiliano,Ruscica ^[2] ; Chiara,Macchi ^[2] ; Alberto,Corsini ^[3] ; Yuji,Matsuzawa ^[4] ; Cesare R,Sirtori ^[5]

作者单位： Rinku General Medical Center, Izumisano, Osaka, Japan; Department of Community Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan. Electronic address: shizu@imed2.med.osaka-u.ac.jp. ^[1] Department of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Milan, Italy. ^[2] Department of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Milan, Italy; IRCCS Multimedica, Milan, Italy. ^[3] Sumitomo Hospital, Osaka, Japan. ^[4] Centro Dislipidemie, A.S.S.T. Grande Ospedale Metropolitano Niguarda, Milan, Italy. ^[5]

关键词 Anacetrapib Cholesteryl ester transfer protein Dalcetrapib Evacetrapib High density lipoproteins Inhibitor Leoligin Probucol Reverse cholesterol transport Torcetrapib